125 related articles for article (PubMed ID: 5643797)
1. Accumulation of dopamine in the parenchyma after decarboxylase inhibition in the capillaries of brain.
Constantinidis J; Bartholini G; Tissot R; Pletscher A
Experientia; 1968 Feb; 24(2):130-1. PubMed ID: 5643797
[No Abstract] [Full Text] [Related]
2. [Selective concentration of dopamine in the parenchyma of the rat brain].
Constantinidis J; Bartholini G; Tissot R; Pletscher A
Helv Physiol Pharmacol Acta; 1967; 25(4):CR411+. PubMed ID: 5586884
[No Abstract] [Full Text] [Related]
3. A rapid fluorescence microscopic method for the study of the capillary DOPA-dopamine barrier.
Jancsó G
J Neurochem; 1975 Mar; 24(3):579-80. PubMed ID: 1113128
[No Abstract] [Full Text] [Related]
4. Differential effect of acute and chronic ethanol on dopamine metabolism in frontal cortex, caudate nucleus and substantia nigra.
Fadda F; Argiolas A; Melis MR; Serra G; Gessa GL
Life Sci; 1980 Sep; 27(11):979-86. PubMed ID: 7432099
[No Abstract] [Full Text] [Related]
5. Brain catecholamines and their metabolites in Parkinsonian patients. Treatment with levodopa alone or combined with a decarboxylase inhibitor.
Rinne UK; Sonninen V
Arch Neurol; 1973 Feb; 28(2):107-10. PubMed ID: 4683147
[No Abstract] [Full Text] [Related]
6. 6-Aminodopamine-induced degeneration of catecholamine neurons.
Jonsson G; Sachs C
J Neurochem; 1973 Jul; 21(1):117-24. PubMed ID: 4720890
[No Abstract] [Full Text] [Related]
7. Mechanism of release of alpha-methylated noradrenaline analogues by monoamine oxidase inhibitors.
Carlsson A; Lindqvist M; Waldeck B
Eur J Pharmacol; 1968 Apr; 3(1):34-9. PubMed ID: 5654667
[No Abstract] [Full Text] [Related]
8. DL-5-hydroxytryptophan-induced changes in central monoamine neurons after peripheral decarboxylase inhibition.
Fuxe K; Butcher LL; Engel J
J Pharm Pharmacol; 1971 Jun; 23(6):420-4. PubMed ID: 4397180
[No Abstract] [Full Text] [Related]
9. Passage into the rat brain of dopa and dopamine injected into the lateral ventricle.
Constantinidis J; Gaillard JM; Geissbuhler F; Tissot R
Br J Pharmacol; 1971 Sep; 43(1):32-8. PubMed ID: 5136462
[TBL] [Abstract][Full Text] [Related]
10. Studies on the enzymatic blood-brain barrier: quantitative measurements of DOPA decarboxylase in the wall of microvessels as related to the parenchyma in various CNS regions.
Hardebo JE; Falck B; Owman C; Rosengren E
Acta Physiol Scand; 1979 Apr; 105(4):453-60. PubMed ID: 452922
[TBL] [Abstract][Full Text] [Related]
11. Animal models for an enzymic blood-brain barrier mechanism for therapeutically administered L-dopa.
Dowson JH
Life Sci; 1973 Jul; 13(1):23-9. PubMed ID: 4753023
[No Abstract] [Full Text] [Related]
12. Quantitative evaluation of the blood-brain barrier capacity to form dopamine from circulating L-DOPA.
Hardebo JE; Edvinsson L; Owman C; Rosengren E
Acta Physiol Scand; 1977 Mar; 99(3):377-84. PubMed ID: 848309
[TBL] [Abstract][Full Text] [Related]
13. Relative penetration of L-dopa and 5-HTP through the brain barrier using dimethyl sulfoxide.
De la Torre JC
Experientia; 1970 Oct; 26(10):1117-8. PubMed ID: 5312418
[No Abstract] [Full Text] [Related]
14. Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition.
Butcher LL; Engel J; Fuxe K
Brain Res; 1972 Jun; 41(2):387-411. PubMed ID: 4402607
[No Abstract] [Full Text] [Related]
15. Dopamine formation in brain capillaries--an enzymic blood-brain barrier mechanism.
Owman C; Rosengren E
J Neurochem; 1967 May; 14(5):547-50. PubMed ID: 6025622
[No Abstract] [Full Text] [Related]
16. Differential effect of benserazide on catecholamine concentrations in the rat pineal, cerebral cortex and hypothalamus.
Ho AK; Smith JA
Biochem Pharmacol; 1983 Dec; 32(23):3605-9. PubMed ID: 6651878
[TBL] [Abstract][Full Text] [Related]
17. [Dopamine metabolism in the rabbit caudate nucleus following partial inhibition of brain monoamine oxidase by nialamide].
Lisch HJ; Aigner A; Hornykiewicz O
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 261(4):289-98. PubMed ID: 4235430
[No Abstract] [Full Text] [Related]
18. Presence of dopaminergic terminals and absence of dopaminergic cell bodies in the cerebral cortex of the cat.
Thierry AM; Hirsch JC; Tassin JP; Blanc G; Glowinski J
Brain Res; 1974 Oct; 79(1):77-88. PubMed ID: 4425954
[No Abstract] [Full Text] [Related]
19. Behavioral and biochemical effects of L-dopa after peripheral decarboxylase inhibition.
Butcher LL; Engel J
Brain Res; 1969 Sep; 15(1):233-42. PubMed ID: 5807767
[No Abstract] [Full Text] [Related]
20. Distribution and metabolism of norepinephrine after its administration into the cerebroventricular system of the cat.
Carr LA; Moore KE
Biochem Pharmacol; 1969 Aug; 18(8):1907-18. PubMed ID: 4390276
[No Abstract] [Full Text] [Related]
[Next] [New Search]
